$10.68
+0.57 (+5.64%)
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 6 60%
Hold 4 40%
Sell 0 0%
Price Target
Analyst Price Target +645.8% upside
Low Target $56.38
Average Target $79.65
High Target $102.54
Current Price $10.68
Current
$10.68
Target
$79.65
$56.38 $79.65 avg $102.54
Scenario Analysis
Bear Case
$56.38
427.9%
Low target
Base Case
$79.65
+645.8%
Avg target
Bull Case
$102.54
+860.1%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$28.22
-62.2% from high
52-Week Low
$9.23
+15.8% from low
50-Day SMA
$14.19
-24.7% vs SMA
200-Day SMA
$20.75
-48.5% vs SMA
RSI (14)
65.7
Neutral
Target vs 52W High
$79.65
+182.2% vs high
Next Earnings Report
Aug 12, 2026
4d
until earnings
EPS Est: $0.35
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +11.9%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +16.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.8%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +30.5%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +172.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.7%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +173.7%